Title : Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.

Pub. Date : 2016 Mar

PMID : 26842788






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RRM1 may be a prognostic and predictive biomarker for PFS in patients with NSCLC who received platinum-based adjuvant chemotherapy, and combining EGFR mutation and RRM1 expression or combining ERCC1 and RRM1 expression can enhance prognostic and predictive power for PFS. Platinum ribonucleotide reductase catalytic subunit M1 Homo sapiens